
Major Suboxone alternatives include buprenorphine, Zubsolv, methadone, naltrexone and Vivitrol.
Suboxone is the gold standard in Medication for Addiction Treatment (MAT) programs and is often a physician’s first choice in treating opioid use disorder (OUD).
Suboxone consists of buprenorphine and naloxone. The naloxone in Suboxone remains inactive unless the drug is taken in very high doses or misused, such as by injecting it. Most often, that component will not be activated if Suboxone is taken sublingually as intended.
The best medication for OUD is one you’ll take regularly without feeling too sick, sedated or upset. If Suboxone doesn’t work for you, trying another option could be a wise decision. Your doctor can guide this process.
Products containing just buprenorphine were available in the U.S. under the brand name Subutex. The manufacturer discontinued them in 2011, but generic forms are available.
Subutex has many of the same benefits as Suboxone. The buprenorphine mechanism of action eases cravings and reduces withdrawal symptoms. Subutex could be right for people in specific populations.
The benefits of Subutex include the following:[2],[3],[4]
Reduced protection is Subutex’s biggest drawback. Without naloxone, it’s slightly easier to overdose on Subutex when compared to Suboxone. It’s also easier for others to steal and misuse your medication.
Zubsolv is another brand name for the combination of buprenorphine and naloxone. However, Zubsolv is a tablet instead of a strip. Zubsolv works much like Suboxone, but important differences exist.
Zubsolv’s benefits include the following:[5]
Zubsolv’s drawbacks include the following:
Studies have repeatedly shown that methadone is effective at reducing opioid misuse and preventing related overdoses.[6] But it comes with drawbacks.
Methadone’s benefits include the following:[7]
Methadone’s drawbacks include the following:
While well-established patients may get the privilege of take-home doses, they still probably need to visit the clinic at least weekly or every other week, which can be challenging. Switching from methadone to Suboxone allows for telemedicine management, which is much more convenient.
Naltrexone is an opioid antagonist and the third FDA-approved medication to treat opioid use disorder, along with methadone and Suboxone. It is not an opioid, unlike Suboxone and methadone. In fact, it is an opioid antagonist, which blocks the effects of opioids, so it works slightly differently in treating OUD than methadone or Suboxone.
Naltrexone’s benefits include the following:
Naltrexone’s drawbacks include the following:
Vivitrol is the brand name of injectable naltrexone used to treat opioid use disorder. It works similarly to oral forms, with a few unique benefits and drawbacks.
Vivitrol benefits include the following:
However, Vivitrol may be slightly less effective than Suboxone in treating OUD.[8] It doesn’t block cravings or treat withdrawal symptoms in the same way that Suboxone does.
Your doctor can help you decide which version of MAT therapy is right for you. But these core details can help you be an active part of your treatment discussion.
SuboxoneBuprenorphine (Subutex)ZubsolvMethadoneNaltrexoneVivitrolTreatment onlineYesYesYesNoYesNoCost$130 (brand name)$112$597$10 $16$1,508EffectivenessHighHighHighHighModerateModerateWhat does it do?Withdrawal, overdose, craving protectionWithdrawal, overdose, craving protectionWithdrawal, overdose, craving protectionWithdrawal, craving protectionPrevents a high during relapsePrevents a high during relapseMisuse potentialLowLowLow ModerateNoneNoneGeneric version available?YesAlways (no brand-name version)No YesYesNo
Buprenorphine, Zubsolv, Vivitrol and methadone have all been shown to be effective in treating opioid use disorder, mitigating withdrawal symptoms and reducing cravings for opioids. Your doctor will assess your situation, including the severity of your OUD and medical history, to determine the best choice of medication for you.
Your OUD therapy choices are vast, and it can be hard to understand why one might be better than another. This video can help you understand how your doctor will guide your recovery and medication choices.

Peter Manza, PhD received his BA in Psychology and Biology from the University of Rochester and his PhD in Integrative Neuroscience at Stony Brook University. He is currently working as a research scientist in Washington, DC. His research focuses on the role of the brain dopamine system in substance use disorders and in aging. He also studies brain function in obesity and eating disorders.
Our science-backed approach boasts 95% of patients reporting no withdrawal symptoms at 7 days. We can help you achieve easier days and a happier future.
Get Startedor book an enrollment call